Coty Inc.
Case Overview
59 Days Left to Seek Lead Plaintiff
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 05/22/2026 |
| Status: | Status: Investigating |
| Company Name: | Company Name: Coty Inc. |
| Court: | Court: Southern District of New York |
| Case Number: | Case Number: 26-cv-02343 |
| Class Period: | Class Period: 11/05/2025 - 02/04/2026 |
| Ticker: | Ticker: COTY |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Coty Inc. (“Coty” or the “Company”) (NYSE:COTY) securities during the period of November 5, 2025 through February 4, 2026, inclusive (“the Class Period”).
The lawsuit alleges that Coty made false and/or misleading statements and/or failed to disclose the true state of Coty’s slowing growth in the beauty market, notably, the Consumer Beauty market was underperforming, margins were compressed by increased marketing investments and there was slowing growth in its Prestige fragrance segment.
On February 4 2026, the Company released prepared remarks for Coty’s second quarter earnings for fiscal year 2026. Among other things, the company stated that “our performance versus the market has been inconsistent. In Prestige fragrances … our sell-out was flattish, underperforming the market by several points in the critical fragrance category. In Consumer Beauty, we continue to see a large gap in our sell-out performance relative to U.S. mass cosmetics category, though the recent changes we implemented are starting to show some modest improvement.” The Company also stated that “[n]ext steps … [include] … leveraging AI to scale content creation at a fraction of the cost and reexamining the full value chain … [w]hile these interventions helped stabilize and grow Consumer Beauty several years ago, operational discipline has slipped across the organization over the past 2 years.” These statements directly contradicted the Company’s statements made during the Company’s first quarter fiscal year 2026 earnings release on November 5, 2025 when Coty supported its original growth outlook for the second half of 2026 through new product launches and brand innovation, operational fixes in the Consumer Beauty segment and AI implementation throughout its operations while also minimizing risks from slowing growth in the beauty market. In truth, Coty’s Consumer Beauty segment was underperforming, margins were compressed by increased marketing investments and there was slowing growth in the Prestige
fragrance market. On this news, the price of Coty shares declined by $0.28 per share, or approximately 8.2%, from $3.43 per share on February 4, 2026 to close at $3.15 on February 5, 2026.
On February 5, 2026, Coty announced its financial results for the second quarter fiscal year 2026, unveiling disappointing earnings results with worsening performance in the Consumer Beauty segment. The Company also noted the recent transition of its Chief Executive Officer in conjunction with the below-expectation results. Coty further withdrew its fiscal year 2026 guidance for EBITDA and revised the Company’s near-term outlook downward. Coty attributed its results and lowered guidance to a combination of macroeconomic factors including rising costs and uncertain consumer demand and lack of “operational discipline” in both Prestige and Consumer Beauty segments. On this news, the price of Coty shares declined by $0.49 per share, or approximately 15.6%, from $3.15 per share on February 5, 2026 to close at $2.66 on February 6, 2026.
The lawsuit alleges that Coty made false and/or misleading statements and/or failed to disclose the true state of Coty’s slowing growth in the beauty market, notably, the Consumer Beauty market was underperforming, margins were compressed by increased marketing investments and there was slowing growth in its Prestige fragrance segment.
On February 4 2026, the Company released prepared remarks for Coty’s second quarter earnings for fiscal year 2026. Among other things, the company stated that “our performance versus the market has been inconsistent. In Prestige fragrances … our sell-out was flattish, underperforming the market by several points in the critical fragrance category. In Consumer Beauty, we continue to see a large gap in our sell-out performance relative to U.S. mass cosmetics category, though the recent changes we implemented are starting to show some modest improvement.” The Company also stated that “[n]ext steps … [include] … leveraging AI to scale content creation at a fraction of the cost and reexamining the full value chain … [w]hile these interventions helped stabilize and grow Consumer Beauty several years ago, operational discipline has slipped across the organization over the past 2 years.” These statements directly contradicted the Company’s statements made during the Company’s first quarter fiscal year 2026 earnings release on November 5, 2025 when Coty supported its original growth outlook for the second half of 2026 through new product launches and brand innovation, operational fixes in the Consumer Beauty segment and AI implementation throughout its operations while also minimizing risks from slowing growth in the beauty market. In truth, Coty’s Consumer Beauty segment was underperforming, margins were compressed by increased marketing investments and there was slowing growth in the Prestige
fragrance market. On this news, the price of Coty shares declined by $0.28 per share, or approximately 8.2%, from $3.43 per share on February 4, 2026 to close at $3.15 on February 5, 2026.
On February 5, 2026, Coty announced its financial results for the second quarter fiscal year 2026, unveiling disappointing earnings results with worsening performance in the Consumer Beauty segment. The Company also noted the recent transition of its Chief Executive Officer in conjunction with the below-expectation results. Coty further withdrew its fiscal year 2026 guidance for EBITDA and revised the Company’s near-term outlook downward. Coty attributed its results and lowered guidance to a combination of macroeconomic factors including rising costs and uncertain consumer demand and lack of “operational discipline” in both Prestige and Consumer Beauty segments. On this news, the price of Coty shares declined by $0.49 per share, or approximately 15.6%, from $3.15 per share on February 5, 2026 to close at $2.66 on February 6, 2026.